(Q34042937)

English

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era (English)

1 reference

Europe PubMed Central

30 July 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Meir J Stampfer

3

object named as

Meir J Stampfer

1 reference

Europe PubMed Central

30 July 2017

Edward Giovannucci

2

object named as

Edward L Giovannucci

1 reference

Europe PubMed Central

30 July 2017

author name string

Jaquelyn L Jahn

1

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

29 December 2014

1 reference

Europe PubMed Central

30 July 2017

International Journal of Cancer

1 reference

Europe PubMed Central

30 July 2017

137

1 reference

Europe PubMed Central

30 July 2017

12

1 reference

Europe PubMed Central

30 July 2017

2795-2802

1 reference

Europe PubMed Central

30 July 2017

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Physician variation in management of low-risk prostate cancer: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Radical prostatectomy or watchful waiting in early prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Overdiagnosis and overtreatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Fish consumption and prostate cancer risk: a review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Statin drugs and risk of advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

The influence of finasteride on the development of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

A prospective study of intake of fish and marine fatty acids and prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485977

5 July 2018

Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

Latent Carcinoma of the Prostate

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

A prospective study of physical activity and incident and fatal prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

How Well Does the Gleason Score Predict Prostate Cancer Death? A 20-Year Followup of a Population Based Cohort in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29408

21 January 2018

Comparative Study of Latent Carcinoma of the Prostate Among Japanese in Japan and Hawaii 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of latent prostate carcinoma in two U.S. populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An autopsy study of latent prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta")

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latent carcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further evidence that prostate-specific antigen screening reduces prostate cancer mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the prostate in patients 70 to 79 years old

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lead-time in the European Randomised Study of Screening for Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lead-time in prostate cancer screening (Finland)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latent prostate carcinoma in Singapore Chinese

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostatic Carcinoma: An Autopsy Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latent prostatic cancer in a consecutive autopsy series

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986

1 reference

https://pubmed.ncbi.nlm.nih.gov/25557753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/IJC.29408

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34042937&oldid=1946633890"